Brightworth’s Elevance Health ELV Stock Holding History

Brightworth’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-790	Closed	-$302K	–	111
2021 Q2	$302K	Buy	+790	New	+$302K	0.03%	91

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Brightworth's ELV Position: Q3 2021 in Review

Brightworth sold out of Elevance Health (ELV) in Q3 2021, closing a stake of 790 shares — an estimated $302K sold.

Brightworth first reported a position in ELV in Q2 2021 and held it in 1 quarter. The position peaked at $302K in Q2 2021. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

Brightworth reported no remaining Elevance Health position as of Q3 2021 after selling out during the quarter.
Brightworth sold 790 Elevance Health shares in Q3 2021, an estimated $302K.
Brightworth first reported a position in Elevance Health in Q2 2021 and held it in 1 quarter.
Brightworth's Elevance Health position peaked at $302K in Q2 2021.
1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Brightworth's 13F filing for Q3 2021, filed 27 Oct 2021.